Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone

NCT00931125 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: ranibizumab and vitrectomy
PROCEDURE: vitrectomy without preoperative ranibizumab

Sponsor

Attila Vajas

Collaborators

[object Object]